Evaluating blood tests for quick pregnancy detection
Official title: Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing
Run by University of Nebraska · NCT06747598 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if a quick blood test from a finger stick can help pregnant people find out their pregnancy status faster than traditional urine tests.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | University of Nebraska Academic / other |
| Locations | 1 site (Omaha, Nebraska) |
| Trial ID | NCT06747598 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant females aged 19 years or older attending the Nebraska Medicine OB/GYN clinic.
✕Probably not a fit
Patients who do not meet the inclusion criteria, such as those who are not pregnant or under 19 years of age, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of using peripheral blood collected via a finger stick for point of care (POC) pregnancy testing in known pregnant individuals. Traditional POC pregnancy tests typically require urine samples, which can delay care, especially in urgent situations. By utilizing blood samples, this approach aims to streamline the testing process, making it more efficient and applicable in various scenarios, including wilderness medicine. The study will gather data to assess the feasibility and reliability of this method compared to conventional urine tests.
Why it matters
Potential benefit: If successful, this method could significantly expedite pregnancy testing and improve care in urgent or non-traditional settings.
How similar studies have gone: Previous studies have shown blood to be a viable alternative for POC pregnancy testing, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant female, 19 years or older, being seen at the Nebraska Medicine OB/GYN clinic Exclusion Criteria: * Does not meet inclusion criteria
Where it's running
-
University of Nebraska Medical Center
Omaha, Nebraska, United States Recruiting
Study contacts
- Principal investigator: Thanh T Nguyen, PhD — University of Nebraska
- Study coordinator: Thanh T Nguyen, PhD
- Email: thang.nguyen@unmc.edu
- Phone: 402-559-7884
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flash-Sole: a wearable midsole that helps you push off while walking
A small, single-session study will test if the Flash-Sole wearable midsole is safe, comfortable, and capable of aiding walking in healthy adults.
-
Inflammation in molars with or without attachments during clear aligner therapy
This study tests whether first molars treated with clear aligners and composite attachments show higher inflammatory markers in gingival fluid than molars treated without attachments.
-
Adaptive ankle exoskeleton controller to personalize walking support
Researchers will test a real-time controller for a robotic ankle exoskeleton that learns how you walk and adds the right amount of help to make walking easier.
-
Enteral nutrition in people receiving allogeneic stem cell transplant
This trial tests whether feeding patients through a tube starting the day after transplant helps people undergoing allogeneic stem cell transplantation compare to the usual care.
-
See if a behavioral coaching plus at-home exercise can help older blood cancer survivors slow aging
Aimed at people 50 and older who have had a blood cancer, this trial tests whether combining coaching with a virtual exercise program can help slow aging and improve health.
-
Abiraterone and prednisone plus ADT versus ADT for PSMA-positive, conventionally node-negative prostate cancer
This trial will test whether adding abiraterone and prednisone to standard androgen-deprivation therapy with radiation helps men whose prostate cancer shows PSMA uptake in small pelvic lymph nodes that are under 1 cm on conventional scans.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.